Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival

被引:76
作者
Hyer, SL [1 ]
Vini, L [1 ]
A'Hern, R [1 ]
Harmer, C [1 ]
机构
[1] Royal Marsden NHS Trust, Thyroid Unit, Sutton, Surrey, England
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2000年 / 26卷 / 07期
关键词
medullary thyroid cancer; local recurrence; prognostic factors; radiotherapy;
D O I
10.1053/ejso.2000.0981
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The aims of this study were to assess the long-term results of treatment of medullary thyroid carcinoma (MTC) and to define prognostic factors. Methods: Retrospective analysis of all patients diagnosed with MTC between 1949 and 1998 and treated in our unit was carried out. Results: One hundred and sixty-two patients (87 females, 75 males) were identified; 52 patients (32%) had familial disease. Median follow-up was 9 years (2-20 years). The majority of patients (90%) presented with a thyroid mass or enlarged neck nodes. Total/subtotal thyroidectomy was performed in 129/18 patients respectively; 45 patients also underwent neck dissection while 52 had simple nodal excision. External beam radiotherapy (RT) was given to 76 patients with advanced disease at presentation. Overall survival was 72% at 5 years and 56% at 10 years case-specific survival was very similar. In multivariate analysis the factors which were significant predictors of survival were age at diagnosis, extent of nodal disease, extent of surgery and metastases at presentation. RT significantly reduced local relapse in patients with ipsilateral nodal disease. Conclusions: MTC may be associated with prolonged survival; the best prognosis occurs in young patients undergoing total thyroidectomy and neck dissection. External beam RT significantly reduces local relapse in patients with limited nodal disease. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:686 / 690
页数:5
相关论文
共 19 条
[1]   Medullary thyroid cancer: Analyses of survival and prognostic factors and the role of radiation therapy in local control [J].
Brierley, J ;
Tsang, R ;
Simpson, WJ ;
Gospodarowicz, M ;
Sutcliffe, S ;
Panzarella, T .
THYROID, 1996, 6 (04) :305-310
[2]  
CHONG GC, 1975, CANCER, V35, P695, DOI 10.1002/1097-0142(197503)35:3<695::AID-CNCR2820350323>3.0.CO
[3]  
2-W
[4]   Medullary thyroid cancer: The role of radiotherapy in local control [J].
Fife, KM ;
Bower, M ;
Harmer, CL .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (06) :588-591
[5]   MEDULLARY-THYROID CARCINOMA - CLINICOPATHOLOGICAL FEATURES AND LONG-TERM FOLLOW-UP OF 65 PATIENTS TREATED DURING 1946 THROUGH 1970 [J].
GHARIB, H ;
MCCONAHEY, WM ;
TIEGS, RD ;
BERGSTRALH, EJ ;
GOELLNER, JR ;
GRANT, CS ;
VANHEERDEN, JA ;
SIZEMORE, GW ;
HAY, ID .
MAYO CLINIC PROCEEDINGS, 1992, 67 (10) :934-940
[6]  
Harmer C. L., 1996, Annals Academy of Medicine Singapore, V25, P413
[7]  
Harmer Clive, 1995, P565
[8]   CHEMOTHERAPY FOR THYROID-CANCER [J].
HOSKIN, PJ ;
HARMER, C .
RADIOTHERAPY AND ONCOLOGY, 1987, 10 (03) :187-194
[9]  
Mak Albert C., 1994, International Journal of Radiation Oncology Biology Physics, V30, P234
[10]   RESULTS OF POSTOPERATIVE RADIATION-THERAPY IN MEDULLARY CARCINOMA OF THE THYROID - A RETROSPECTIVE STUDY BY THE FRENCH-FEDERATION-OF-CANCER-INSTITUTES - THE RADIOTHERAPY-COOPERATIVE-GROUP [J].
NGUYEN, TD ;
CHASSARD, JL ;
LAGARDE, P ;
CUTULI, B ;
LEFUR, R ;
REMESAUMON, M ;
PREVOST, B ;
PANIS, X ;
VERRELLE, P ;
CHAPLAIN, G .
RADIOTHERAPY AND ONCOLOGY, 1992, 23 (01) :1-5